Print

Amgen (AMGN) Drug Shows Promise In Ovarian Cancer  
5/21/2010 7:53:11 AM

NEW YORK, May 20 (Reuters) - An experimental drug being developed by Amgen Inc (AMGN.O) appeared to keep recurrent ovarian cancer in check longer when combined with chemotherapy than chemotherapy alone, according to a summary of data from a mid-stage study.
//-->